Aberrant Histone Methylation in Patients with Graves’ Disease

Figure 1

Global histone methylation levels in PBMCs from patients of GD and healthy controls. Mean global histone H3K9 methylation level was significantly decreased in PBMCs from GD patients in contrast to healthy controls (, P=0.007).